TEMPLE, Texas – A collaborative team of leading researchers and physicians from Orion Institute for Translational Medicine, Emergent Biotechnologies LLC, Advance Pharmaceutical Inc., and Texas A&M University School of Medicine announced a significant breakthrough in combating oxidative stress-related neurodegenerative disorders using Revivify Gel. This groundbreaking study points to a promising new direction for mitigating the pathogenesis of diseases like Parkinson's Disease (PD), Multiple Sclerosis (MS), and Alzheimer's Disease (AD).
Revivify Gel, developed by Advance Pharmaceutical Inc., has been demonstrated to provide immediate relief from oxidative stress using multi-dimensional pathways. The latest study focuses on the potential for Revivify Gel to protect human brain microvascular endothelial cells (HBMEC) from oxidative damage and mitigate hypoxia-induced disruption of the blood-brain barrier.
"In vitro models show that Revivify Gel significantly reduces the permeability of the blood-brain barrier caused by hypoxia. This discovery has broad implications for addressing neurodegenerative disorders that arise from oxidative stress," said Zubayeer Alam, a spokes person for Revivify. "Our results point to the potential of Revivify Gel to improve motor activity, muscle stiffness, memory response, and overall body responses related to diseases like PD and AD."
Revivify Gel's unique composition includes Superoxide Dismutase, prebiotic fiber, and fruit juice, a combination that has shown unprecedented results in attenuating oxidative stress. The study also suggests that the pre-biotic soluble corn fiber component of Revivify Gel encourages a healthy gut ecosystem, thereby influencing various positive neurological effects through the gut-brain bi-directional axis.
"These results are a testament to our mission to bring innovative, transformative solutions to the health and wellness sector," said Alam. "We're thrilled about the potential of Revivify Gel to provide prompt responses to neuro-disease-induced symptoms in conditions like PD, MS, AD, and others."
The patent for Revivify Gel is held by Advance Pharmaceutical Inc., an industry leader in novel drug formulations. This pioneering product stands as a testament to the benefits of collaborations between academia and industry, ultimately paving the way for a healthier future.
Click on Image for more information.
About Emergent Biotechnologies LLC
Emergent Biotechnologies is a leading biotechnology firm based in Temple, Texas, committed to leveraging innovative technology to address challenging health problems. Working at the forefront of scientific research, Emergent Biotechnologies delivers transformative solutions to global healthcare challenges.
About Advance Pharmaceutical Inc.
Located in Holtsville, NY, Advance Pharmaceutical Inc. is a dynamic pharmaceutical company dedicated to developing advanced drug formulations to improve the quality of life for people worldwide. They manufacture REVIVIFY® products.
About Revivify For Life
REVIVIFY® is a high-quality, patented, and advanced health supplement manufactured with primary antioxidants delivered at a cellular level. Our company is based out of New York and can ship our products anywhere in the world. REVIVIFY® products are patented (U.S. Patent: 11, 224, 636). Check out the science behind these products and how it works on a cellular level.
For media inquiries, please contact:
Zubayeer Alam
Advance Pharmaceutical Inc.
zalam@advancepharmaceutical.com